Schizophrenia & Other Psychotic Disorders
From the Journals
Positive Phase 3 Results for Novel Antipsychotic in Schizophrenia
Xanomeline is an oral muscarinic cholinergic receptor agonist that does not have direct effects on the dopamine receptor.
From the Journals
Spike in Schizophrenia-Related ED Visits During COVID
Prior studies indicated that COVID-19 infections may induce psychosis in some individuals, which could have been one underlying factor in the...
From the Journals
Higher-Dose Atypical Antipsychotics Risky in Young Adults
The findings point to a need for caution when prescribing any antipsychotic medications off label, said Dr. Anish Dube.
Commentary
Cannabis for Psychiatric Disorders? ‘Not Today,’ Experts Say
Media and the state legislatures speak about cannabis as a medication for the treatment of psychiatric conditions before there is sufficient...
Latest News
ADHD Plus Comorbidities Linked to Increased Schizophrenia Risk
Participants with one psychiatric comorbidity had a 2.1-fold increased risk for a schizophrenia diagnosis than participants with no comorbidity....
Opinion
Toward a better framework for postmarketing reproductive safety surveillance of medications
We want to empower patients to make decisions that work for them based on more rapidly accumulating information and help inform their decisions....
Evidence-Based Reviews
Breastfeeding by patients with serious mental illness: An ethical approach
Our framework can guide decisions about breastfeeding on a psychiatric unit.
Commentary
Mass shooters and mental illness: Reexamining the connection
Untreated mental illness combined with access to firearms poses a lethal threat to society.
Evidence-Based Reviews
Delirious mania: Presentation, pathogenesis, and management
Rapid recognition is critical to avoid initiating inappropriate treatment.
Evidence-Based Reviews
Cannabis and schizophrenia: A complex relationship
For some who are predisposed to psychosis, cannabis may trigger or exacerbate symptoms.
Cases That Test Your Skills
Symptoms of psychosis and OCD in a patient with postpartum depression
Ms. A, age 37, has a history of postpartum depression. Four months after giving birth, she presents with possible auditory hallucinations and...